Neuroone Medical Technologies is trading higher amid a broad market rally following weaker-than-expected U.S. payroll data.
- Shares are trading at $1.10 (+11.64%).
- September payrolls rose by 29,000, below expectations, while unemployment reached 4.2%; falling Treasury yields and reduced rate-hike concerns supported equities.
- No clear company-specific catalyst for the October 2 move was identified; the available company-news search showed earlier announcements, not a same-day event.